Browse
Search
Agenda - 01-23-2018 4-b - Presentation on Opioids and Legal Issues
OrangeCountyNC
>
Board of County Commissioners
>
BOCC Agendas
>
2010's
>
2018
>
Agenda - 01-23-2018
>
Agenda - 01-23-2018 4-b - Presentation on Opioids and Legal Issues
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
1/22/2018 10:49:04 AM
Creation date
1/22/2018 8:39:31 AM
Metadata
Fields
Template:
BOCC
Date
1/23/2018
Meeting Type
Regular Meeting
Document Type
Agenda
Agenda Item
4-b
Document Relationships
Agenda - 01-23-2018 - Regular Meeting Agenda
(Message)
Path:
\Board of County Commissioners\BOCC Agendas\2010's\2018\Agenda - 01-23-2018
Minutes 01-23-2018
(Message)
Path:
\Board of County Commissioners\Minutes - Approved\2010's\2018
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
24
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
C! <br />Overview Memorandum <br />Prospective North Carolina County Opioid Litigation <br />North Carolina is in the midst of a public health crisis stemming from the flood of opioids <br />pouring into the State, as well as North Carolina's Cities and Counties. The opioid epidemic has <br />been fueled by the greed of the corporate elite, such as Fortune 500 behemoth McKesson Corp., <br />deliberately failing to detect and report "suspicious" orders of opioids, despite being required to <br />do so by federal and state law. In 2017, McKesson, the largest drug distributor in the nation, <br />was fined a record $150 million by the federal government for its blatant failure to report <br />suspicious orders in violation of federal law. Cardinal Health, another member of the "Big <br />Three" drug distributors, was fined $44 million for its failure to report suspicious narcotic <br />orders to the DEA. <br />Substantially all prescribed opioids must flow through the distributors: federal law <br />requires that opioids be distributed through a closed system. Accordingly, the distributors are <br />legally required to spot and report red flags in the distribution chain. <br />McKesson, Cardinal, and their fellow distributors admit that they are the gatekeepers — <br />the watch dogs — for preventing opioid abuse, stating in their self - created Industry Compliance <br />Guidelines: "distributors are uniquely situated to perform due diligence in order to help <br />support the security of the controlled substances... and reduce the possibility that controlled <br />substances within the supply chain will reach locations they are not intended to reach."� <br />Unfortunately, the distributors wholly ignored their admitted legal obligations. Instead of <br />putting in controls to stop opioid abuse and alerting authorities to suspicious orders, the <br />' See Healthcare Distribution Management Association (HDMA) Industry Compliance <br />Guidelines: Reporting Suspicious Orders and Preventing Diversion of Controlled Substances <br />( "industry Compliance Guidelines" or "Guidelines "). <br />North Carolina County Opioid Litigation - Privileged and Confidential <br />
The URL can be used to link to this page
Your browser does not support the video tag.